Search results
Results from the WOW.Com Content Network
Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing.
CRSP | Complete CRISPR Therapeutics AG stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Stock analysis for CRISPR Therapeutics AG (CRSP:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Get the latest Crispr Therapeutics AG (CRSP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
A high-level overview of CRISPR Therapeutics AG (CRSP) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
According to 19 analysts, the average rating for CRSP stock is "Buy." The 12-month stock price forecast is $73.69, which is an increase of 56.89% from the latest price.
Discover real-time CRISPR Therapeutics AG Common Shares (CRSP) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
View the latest CRISPR Therapeutics AG (CRSP) stock price, news, historical charts, analyst ratings and financial information from WSJ.
The latest CRISPR Therapeutics stock prices, stock quotes, news, and CRSP history to help you invest and trade smarter.
CRISPR Therapeutics AG Common Shares (CRSP) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.